ZA987904B - Use of sulfated oligosaccharides as inhibitors of cardiovascular disease - Google Patents

Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Info

Publication number
ZA987904B
ZA987904B ZA987904A ZA987904A ZA987904B ZA 987904 B ZA987904 B ZA 987904B ZA 987904 A ZA987904 A ZA 987904A ZA 987904 A ZA987904 A ZA 987904A ZA 987904 B ZA987904 B ZA 987904B
Authority
ZA
South Africa
Prior art keywords
inhibitors
cardiovascular disease
sulfated oligosaccharides
sulfated
oligosaccharides
Prior art date
Application number
ZA987904A
Other languages
English (en)
Inventor
William Butler Cowden
Douglas J Francis
Christopher Richard Parish
Original Assignee
Australian Nationa University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian Nationa University filed Critical Australian Nationa University
Publication of ZA987904B publication Critical patent/ZA987904B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA987904A 1997-09-01 1998-08-31 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease ZA987904B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO8884A AUPO888497A0 (en) 1997-09-01 1997-09-01 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Publications (1)

Publication Number Publication Date
ZA987904B true ZA987904B (en) 1999-03-01

Family

ID=3803170

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA987904A ZA987904B (en) 1997-09-01 1998-08-31 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Country Status (11)

Country Link
US (1) US6638916B1 (fr)
EP (1) EP1024813A4 (fr)
JP (1) JP2001514229A (fr)
CN (1) CN1272060A (fr)
AU (1) AUPO888497A0 (fr)
BR (1) BR9811422A (fr)
CA (1) CA2302154A1 (fr)
IL (1) IL134761A0 (fr)
TW (1) TW438594B (fr)
WO (1) WO1999011273A1 (fr)
ZA (1) ZA987904B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
US20050186645A1 (en) 2003-12-18 2005-08-25 Yehudit Amor Method for analyzing a glycomolecule
WO2009000935A1 (fr) * 2007-06-28 2008-12-31 Basf Beauty Care Solutions France Sas Composition d'amaigrissement
JP7158096B2 (ja) 2014-07-09 2022-10-21 カデナ バイオ，インコーポレーテッド オリゴ糖組成物及びその生成方法
ES2755042T3 (es) 2015-01-26 2020-04-21 Cadena Bio Inc Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas
EP3285777B1 (fr) 2015-04-23 2021-06-09 Kaleido Biosciences, Inc. Agents thérapeutiques de glycanes et procédés de traitement
WO2017083520A1 (fr) * 2015-11-13 2017-05-18 Cadena Bio, Inc. Compositions alimentaires et thérapeutiques pour animaux et méthodes d'utilisation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55105700A (en) * 1979-02-09 1980-08-13 Yamasa Shoyu Co Ltd S-adenosyl-l-methionine-containing composition and its preparation
FR2535324A1 (fr) * 1982-10-27 1984-05-04 Choay Sa Station perfectionnee pour l'epuration d'eaux usees
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
US5298616A (en) * 1990-10-03 1994-03-29 Hoffmann-La Roche Inc. Sulfated O-polysaccharide-trehaloses
IT1242604B (it) * 1990-11-13 1994-05-16 Alfa Wassermann Spa Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazione e formulazioni farmaceutiche che li contengono.
CA2061370A1 (fr) * 1991-03-13 1992-09-14 Markus Hosang Preparations phramaceutiques
CA2108569A1 (fr) * 1991-04-17 1992-10-18 H. Edward Conrad Polysaccharides sulfates utilises comme inhibiteurs de la proliferation des cellules musculaires lisses
IT1251182B (it) * 1991-08-28 1995-05-04 Opocrin Spa Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
EP0612249A4 (en) 1991-11-11 1995-11-08 Univ Pennsylvania Methods of inhibiting restenosis.
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5739115A (en) * 1993-10-07 1998-04-14 Glycomed Incorporated Sulfated maltooligosaccharides with heparin-like properties
CA2171465A1 (fr) * 1993-10-07 1995-04-13 Peter Fugedi Maltooligosaccharides fortement sulfatees presentant des proprietes semblables a l'heparine
WO1995033468A1 (fr) 1994-06-06 1995-12-14 Oestergaard Per Bjoern Composition pharmaceutique contenant des oligosaccharides se liant a une lipoproteine lipase
US5464827A (en) * 1994-06-20 1995-11-07 American Home Products Corporation Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
WO1997022628A1 (fr) * 1995-12-20 1997-06-26 Taiho Pharmaceutical Co., Ltd. Inhibiteur d'epaississement de la membrane intravasculaire

Also Published As

Publication number Publication date
EP1024813A4 (fr) 2002-08-28
US6638916B1 (en) 2003-10-28
CA2302154A1 (fr) 1999-03-11
BR9811422A (pt) 2000-08-22
AUPO888497A0 (en) 1997-09-25
EP1024813A1 (fr) 2000-08-09
TW438594B (en) 2001-06-07
WO1999011273A1 (fr) 1999-03-11
JP2001514229A (ja) 2001-09-11
IL134761A0 (en) 2001-04-30
CN1272060A (zh) 2000-11-01

Similar Documents

Publication Publication Date Title
EP1131415A4 (fr) Production d'oligosaccharides bon marche
IL142490A0 (en) ENZYMATIC SYNTHESIS OF ssDNA
ATE249189T1 (de) Körperreinigungsmittel
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
GB2323530B (en) Amelioration of dupuytrens disease
ZA982050B (en) Sulfated oligosaccharides having anticoagulant/antithrom-botic activity
PL339176A1 (en) Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase
GB9717949D0 (en) Cleansing compositions
GB9717947D0 (en) Cleansing compositions
IL134761A0 (en) Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
PL341561A1 (en) Dish-washing agent compact of specific solubility
PL339186A1 (en) Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase
ID24927A (id) Proses sintesis zat-antara kloropurin
ZA989314B (en) Use of sulfated oligosaccharides in lowering blood triglyceride levels
IT1290071B1 (it) Sintesi completamente transglicolica di oligosaccaridi ramificati
GB9700946D0 (en) Manufacture of elongate members
PL325816A1 (en) Novel derivatives of naphtylpiperazine
GB9717951D0 (en) Cleansing compositions
ZA963356B (en) Novel uses of heptafluoropropane
TW400949U (en) Improved structure of leveller
AU3894500A (en) Prevention of cardiovascular disease
GB9713139D0 (en) Use of enzymes
TW320013U (en) Improved structure of shoes cabinet
TW309934U (en) Structure of cigarrette shelf
GB9907465D0 (en) Beat pads